Start-ups weigh benefits of corporate incubators
Nature Biotechnology, March 2008
Cellulosic ethanol booms despite unproven business models 
Nature Biotechnology, January 2008
Profile: Doug Cameron 
Nature Biotechnology, November 2007
Tracking down tissues
Nature Biotechnology, November 2007
Industry waits for fallout from Cabilly
Nature Biotechnology, July 2007
Will the current biofuels boom go bust?
Nature Biotechnology, May 2007
News brief: BIO global conference
Nature Biotechnology, July 2007
Epilepsy controlled by low-carb diet's effect on brain channels
Nature Medicine, May 2007
News briefs: 
Biofuels bandwagon
Cabilly II revoked, again
Nature Biotechnology, April 2007
Pricey cancer genome project struggles with sample shortage
Nature Medicine, April 2007
Supreme Court boosts licensees in biotech patent battles
Nature Biotechnology, March 2007
Sidebar: Three more robotic first responders
Outside, March 2007
US proposal to expand access to untested drugs draws fire
Nature Medicine, February 2007
Practical malaria tests promise results in remote regions
Nature Medicine, January 2007
Lou Gehrig's group dangles million-dollar bait for biomarker search
Nature Medicine, December 2006
Profile: Ken Catania; Mole man gets the MacArthur
Seed (online), October 19, 2006

An eye on: Mony de Leon
Nature Medicine, July 2006
Informed consent issue hobble cancer genome scheme
Nature Medicine, July 2006
US court rules to allow experimental drugs for dying patients
Nature Medicine, June 2006
News briefs:
FDA advisor conflicts and voting weakly linked
E&Y study cites industry 'stability'
Nature Biotechnology, June 2006
News brief: Former FDA chief faces criminal charges
Nature Biotechnology, June 2006
Pandemic prevention schemes threaten diversity, experts warn
Nature Medicine, June 2006
The body snatchers
Nature Medicine, May 2006
US drug approval ignores science's subtleties, experts say
Nature Medicine, April 2006
News briefs:
Bush's pick for FDA chief faces disputes
Embattled Harvard president to step down
Global stem cell guidelines proposed
Companies renege on most follow-up studies
Industry-funded studies see dramatic rise
Nature Medicine, April 2006
News briefs:
US, UK clash over funds for AIDS, abortion
Biologists' secrecy said to stall science
Cloning scandal spells trouble for US collaborator
Nature Medicine, March 2006
After criticism, more modest cancer genome projects takes shape
Nature Medicine, March 2006
Profile: Robert Tjian
Nature Medicine, March 2006
Biotech entrepreneur, educate thyself
Bioentrepreneur, December 15, 2005
News briefs:
Drug makers still secretive about trial results
Norway set to push law to punish scientific fraud
Intermittent AIDS therapy is dangerous, trial shows
Terrorist attack spooks Indian scientists
Depression drugs safe, says new study
Nature Medicine, February 2006
New York's scheme to track diabetes stirs privacy concerns
Nature Medicine, February 2006
News briefs:
French government passes unpopular research bill
Resistance emerges to new malaria drug
US requests mandatory anthrax shots for military
Pfizer launches large Celebrex safety study
Ethical concerns greet first face transplant
Nature Medicine, January 2006
US ponders unlocking the gates to prisoner research
Nature Medicine, January 2006
Biotech on Fashion Island?
Bioentrepreneur, December 1, 2005
Price of mice to plummet under NIH's new scheme
Nature Medicine, December 2005
GlaxoSmithKline cancer drug threatens Herceptin market
Nature Biotechnology, December 2005
News briefs:
French government tech fund
Chiron acquired by Novartis
Selected research collaborations
Nature Biotechnology, December 2005
News briefs:
HapMap yields clues to human diseases
Immunologist admits to falsifying data
Bush's bird flue plan promotes vaccines
Risk of birth defects rises with men's age
Nature Medicine, December 2005
Nanobiotech booster shots
Bioentrepreneur, November 3, 2005
News brief: Cabilly patent invalidated
Nature Biotechnology, November, 2005
News briefs: 
Research on ulcers, organic catalysts garner Nobels
New stem cell methods evade ethical concerns
More women win with NIH's revised awards
Resistance to bird flu rises
Nature Medicine, November, 2005
The body shop: the self-repairing athlete
Outside, September, 2005

selected stories
News brief: Four rebuffs for Cabilly
Nature Biotechnology, April 2008
Alternatives to ebay for the eco set
Plenty (online), April 14, 2008
Leasing the ocean for wind harvesting
Plenty (online), May 12, 2008
News brief: Biofuels, take two
Nature Biotechnology, July 2008
Distinguishing green ecotourism operations
Plenty (online), July 23, 2008
News brief: Cabilly patent finale
Nature Biotechnology, August, 2008
An infamous intellectual property battle ended when Genentech and MedImmune settled a lawsuit over the validity of Genentech’s Cabilly 2 patent, a basic method for producing therapeutic antibodies. The patent remains valid, allowing Genentech to continue reaping steep royalties from its licensees.
Do biomaterials really mean business?
Nature Biotechnology, August 2008
Western biotechs ponder follow-on possibilities
Nature Biotechnology, September 2008




News brief: Startups lure oil giants
Nature Biotechnology, September 2008
Genetically manipulating algae for fuel
Plenty (online), September 18, 2008
News brief: Plant biotech bonanza
Nature Biotechnology, October, 2008
Offshore wind may power the future
Scientific American (online), October 20, 2008
FDA launches priority vouchers for neglected-disease drugs
Nature Biotechnology, December, 2008
Feature: Biotech's green gold
Nature Biotechnology, January, 2009
News brief: Plant genomics land big prizes
Nature Biotechnology, January, 2009
News brief: FDA goes public-friendly
Nature Biotechnology, February, 2009
Comparative effectiveness casts first shadows across US
Nature Biotechnology, March, 2009



Generic biologic drugs aren't yet permitted in the US, but several North American biotech companies are ramping up preparations to be the first to produce such drugs for the US market. 
Stuffed into the US stimulus package is a provision that biotech companies fear will allow the federal government to restrict patients’ access to approved drugs.
People dying from a terminal illness have the right to buy experimental drugs from companies before the US Food and Drug Administration (FDA) has approved them, a US federal appeals court ruled in May.
A multiple sclerosis drug yanked off the market last year is on track to return, prompting some experts to say it should perhaps not have been withdrawn in the first place. 
Some companies making fuel from algae are misleading the public and investors about their capabilities. This story exposes the junk science in the algal biofuels industry.    
The US Food and Drug Administration (FDA) has launched a new program intended to encourage companies to develop treatments for the neglected diseases of developing countries.
The federal government is about to open up to wind energy development vast swaths of deep ocean waters. New Jersey is vying to be the first to seize the new frontier. 
Three start-up biotech companies in January began their lives under the shelter of corporate incubators built by Biogen Idec and Pfizer. The incubators offer a stable beginning for fledgling companies, but the start-ups must be willing to pay the ultimate price: the parents provide space, expertise and capital in exchange for acquisition rights after two to three years.
Conscientious consumers might look for the organic label when buying milk and the Fair Trade logo when purchasing coffee, but finding a certified ecotourism operation for your next vacation isn’t so straightforward.
New online marketplaces offer everything from home biodiesel processors to reclaimed lumber.
Consolidation in the young biofuel industry illustrates a trend of moving away from first-generation biofuels derived from food crops such as corn, sugarcane and oilseed, and toward the next generation, made from more plentiful lignocellulosic feedstocks such as corn stover, grasses and wood chips.
News brief: Cellulosic ethanol stimulus
Nature Biotechnology, April, 2009
Genentech's Cabilly victory
Nature Biotechnology, April, 2009
A four-year battle over one of the most ubiquitous patents in biotech ended with the US patent office siding with Genentech.
Hurdles in Hungary
Forced into entrepreneurialism by Hungary's transition from socialism to a free-market economy, Hungarian scientist Gyorgy Keri founded one of his country's first biotech companies.
Spanish Spin-offs
Of all the things that a city could be known for, a solid supply of human-tissue samples is the least sexy. But it is this feature that has helped make Barcelona a hub for biotech start-up companies focused on cancer.
Mexico's manufacturing move
For as long as the biotechnology industry has been around, Mexico has required international drug makers who want to sell their products there to manufacture them there too. That has changed, thanks to new rules that have left some Mexican experts a little uneasy. 
Biotech stories from four countries: Hungary, Brazil, Mexico & Spain
Scientific American Worldview, May, 2009
Cellulose in Campinas
New ethanol projects in Brazil signal the country's shift from sugarcane to cellulosic sources of fuel.
Hungry for GM crops
Scientific American Worldview, May, 2009
Scientists' attempts to bring biotech crops to hungry people have been thwarted by regulations. Here's the story of Dennis Gonsalves' failed attempt to save Thailand's papaya.
News brief: Algae Trailblazer Shuts 
Nature Biotechnology, July, 2009
Battlefield
Nature, September 3, 2009
Scientists who suggest that biotech crops might harm the environment attract a hail of abuse from other scientists. Are the critics fighting fair?
Scum Artists
Mother Jones, October, 2009
Some companies making fuel from algae have promised impossible amounts of oil based on speculation, raising millions from unwitting investors. 
Under Wraps
Nature Biotechnology, October, 2009
The seed industry’s strong-arm tactics and close-fisted attitude may be holding back independent research and public acceptance of biotech food.
News briefs: 
Courts upbraid USDA for lax review of GM sugar beets
German and American 'GMO-free' logos
Surprise supreme court ruling eases diagnosic makers' fears
Nature Biotechnology, November, 2009
News briefs: 
China's GM rice first
Plant genomics' ascent
Nature Biotechnology, January, 2010
Roger Beachy Q&A
Nature Biotechnology, January, 2010
President Obama chose Roger Beachy, head of the Danforth Plant Science Center, to run the newly created National Institute of Food and Agriculture. Waltz talks to Beachy about his plans for the agency.
Frankenfoods that could feed the world
Discover, January 19, 2010
An online photo essay of seven genetically modified crops designed to help world's neediest.
US government directs stimulus funding to biofuel start-ups 
Nature Biotechnology, February, 2010
Argentine farmers seek sustainable agriculture certification
Scientific American Worldview, May, 2010
Tough weeds threaten biotech crops, report says
Nature Biotechnology, June, 2010
Shell plunks $12 billion into Brazilian ethanol venture 
Nature Biotechnology, April, 2010
Waltz visits Argentine farmer to discuss his plan to recognize growers who practice sustainable agriculture. 
Weeds are becomming increasingly resistant to major herbicides and threatening the effectiveness of herbicide-tolerant crops.
10 science hotspots: where mother nature reveals her secrets
Discover, June 30, 2010
Pioneer develops  biotech soybean with improved oil content 
Nature Biotechnology, August, 2010
Mouse maker Jackson Laboratory fends off patent lawsuits
Nature Biotechnology, August, 2010
Censorship of science
Nature, October 14, 2010
Monsanto strikes deal with USDA crop scientists
Nature Biotechnology, October, 2010
DNA not patentable, says Department of Justice
Nature Biotechnology, December, 2010
USDA okays GM alfalfa
Nature Biotechnology, March, 2011
GM ethanol corn drawing objections from biotech supporters
Nature Biotechnology, April, 2011
EPA proposes to exempt certain biotech plants from regulation
Nature Biotechnology, August, 2011
Biotech lawn grass bypasses USDA oversight
Nature Biotechnology, September, 2011
EU high court says honey with traces of GM pollen must pass regulatory approval 
Nature Biotechnology, November, 2011
Cold-tolerant trees win
Nature Biotechnology, December, 2011
Medical device maker under investigation
Nature Biotechnology, January, 2012
Tiptoeing around transgenics
Nature Biotechnology, March, 2012
New techniques for manipulating plant genomes are yielding plants touted as nontransgenic and may bypass federal regulations.
1000 Genomes on Amazon's Cloud
Nature Biotechnology, May, 2012
An in-depth look at a Chinese manufacturer of biobutanal and long chain diacids
Newsmaker: Cathay Industrial Biotech
Nature Biotechnology, June, 2012
A Modern Green Revolution
Scientific American Worldview, June, 2012
White House Plan Reveals Support for Biotech
Nature Biotechnology, July, 2012
Investors Boost Canadian Biotech Startups
Nature Biotechnology, August, 2012
Biotech Industry Cautiously Welcomes Supreme Court Decision on Healthcare Reform
Nature Biotechnology, September, 2012
How I Quantified Myself
IEEE Spectrum, September, 2012
Can self-measurement tools help us live healthier and better lives? Waltz wears five such gadgets for two months in an attempt to find out.
Five Stories From the Front Lines of the Quantified Self Movement
IEEE Spectrum, September, 2012
How sedentary office workers, anxious parents and obsessive data geeks are using health and fitness trackers
GM Sugar Beets Get USDA Approval
Nature Biotechnology, October, 2012
Reading and Writing a Book With DNA
IEEE Spectrum August, 2012
Bacterial Shield for Seeds
Nature Biotechnology, November, 2012
Algal Biofuels Questioned
Nature Biotechnology, January, 2013
Spinal Stimulation Gets Paralyzed Patients Moving
IEEE Spectrum, November, 2013
The author observes experiments in which researchers stimulate the spinal cord of a paralyzed man to help him stand on his own. 
Sowing Solutions: addressing global hunger through agbiotechnology
Scientific American Worldview 2013
The author profiles three agbiotech experts who have worked to address global hunger through agbiotech.
Rafina Yasmin Othman
A scientist steps out of her comfort zone to help her country succeed
Adrian Dubock
The manager who found a way for his seed corporation to develop a humanitarian crop and give it away for free
Clive James
The go-to source for biotech crop data
GM Crop Protection Act Fizzles
Nature Biotechnology, November 2013
Perrigo Buys Elan, Gains Irish Domicile
Nature Biotechnology, November 2013
Take Two Apps and Call Me in the Morning
IEEE Spectrum, January, 2014
BlueStar, the first prescription-only app. 
Mesoblast acquires Osiris' Stem Cell Business
Nature Biotechnology, December, 2013
Beating the Heat
Nature Biotechnology, July, 2014
The search for drought-tolerant crops.
Agricultural Espionage
Nature Biotechnology, July, 2014
Employees of a Chinese seed company charged with consipring to steal trade secrets from Monsanto, Pioneer.
Super Bananas
Nature Biotechnology, September, 2014
The first human trial of a GM nutritionally enhanced banana is set to begin in the U.S.
New Probes Replace Surgeon's Sense of Touch
IEEE Spectrum, January 22, 2014
Laparoscopic pressure sensors make 3-D maps of tumors.
Text-a-Doctor App Gets Big Venture Capital Boost
IEEE Spectrum, January 7, 2015
Free medical advice by smartphone: effective? safe? legal? Emily tried it out using a set of symptoms her son had.
USDA Approves Next-Generation Potato 
Nature Biotechnology, January, 2015
J.R. Simplot to commercialize first genetically modified non-browning potato. Spuds would be the only GM potato on the market.
Engineers of Scent
Nature Biotechnology, April, 2015
Companies exploring biotech approaches to flavor and fragrance production must navigate public perception and market challenges.
Genetically Modified Apple Cleared for Market
Nature Biotechnology, Bioentrepreneur, March 30, 2015
Monsanto Adds Herbicide Dicamba to its Cache to Fight Weed Threat
Nature Biotechnology, April, 2015
Another Genetically Modified Grass from Scotts Miracle-Gro Falls Outside USDA's Regulatory Purview
Nature Biotechnology, March, 2015
Medtronic deal flurry raises artificial pancreas prospects
Nature Biotechnology, June, 2015
The Quantified Olympian: Wearables for Elite Athletes
IEEE Spectrum, May 28, 2015
First stress-tolerant soybean gets go-ahead in Argentina
Nature Biotechnology, July, 2015
Oxitec Trials GM Moth to Combat Agricultural Infestation
Nature Biotechnology, August, 2015
Q&A with Biotech Billionaire Randal J. Kirk
Nature Biotechnology, October, 2015
Tasting and Testing a Genetically Modified, Non-browning Apple
The New York Times, November 10, 2015
A Facelift for Biotech Rules Begins
Nature Biotechnology, December, 2015
GM Salmon Declared Fit for Dinner Plates 
Nature Biotechnology, January, 2016
Drugs Go Wireless
Nature Biotechnology, January, 2016
Software Helps Gene Editing Tool CRISPR Live Up to its Hype
IEEE Spectrum, February 22, 2016
GM Mosquitoes Fire First Salvo Against Zika Virus
Nature Biotechnology, March 1, 2016
Seed Spy Pleads Guilty
Nature Biotechnology, March 2016
Portable DNA Sequencer MinION Helps Build Internet of Living Things
IEEE Spectrum, March 17, 2016
The Dial-a-Drug Machine
IEEE Spectrum, March 31, 2016
Gene-edited CRISPR Mushroom Escapes USDA Regulation
Nature, April 14, 2016
Rocky Start for Wearables in Professional Sports Games
IEEE Spectrum, April 15, 2016
Jet-Lag Sleep App is Viable Way to Collect Big Data
IEEE Spectrum, May 6, 2016
Wrist Wearable Wins Alcohol Biosensor Contest 
IEEE Spectrum, May 19, 2016
US Reviews Plan to Infect Mosquitoes with Bacteria to Stop Disease 
Nature, May 24, 2016
Lab mosquitoes carrying Wolbachia could stop spread of Zika, Dengue
Wearable Turns Baseball Pitching Into a Science
IEEE Spectrum, August 21, 2015
Telephone Hotline Data Can Predict Dengue Outbreaks in Pakistan Three Weeks Ahead
IEEE Spectrum, July 8, 2016
Brazil's High-Tech Drug-Testing Lab Back in Business Two Weeks Before 2016 Olympic Games
IEEE Spectrum, July 20, 2016
New Tech to Find Cheaters at the 2016 Olympics
IEEE Spectrum, July 25, 2016
Sloppy Spinal Stimulation Studies Scrutinized
IEEE Spectrum, August 18, 2016
Olympic Athletes Try Zapping Their Brains to Boost Performance
IEEE Spectrum, August 4, 2016
A Spark at the Periphery
Nature Biotechnology, September 8, 2016
Devices that electrically stimulate the peripheral nervous system come to the fore.
Bayer Bids $66 Million for Monsanto
Nature Biotechnology, October 11, 2016
From Passwords to Passthoughts: Logging In to Your Devices With Your Mind
IEEE Spectrum, August 31, 2016
Don't Like Their Faces? Train Your Brain to Feel More Positively
IEEE Spectrum, September 16, 2016
The Tell-tale Heart: Researchers 3D Print Organ-on-a-chip
IEEE Spectrum, October 27, 2016
Controlling a Hand Exoskeleton With Your Mind 
IEEE Spectrum, December 7, 2016
Human Cells Eat Nanowires 
IEEE Spectrum, December 19, 2016
U.S. Government Awards $20 Million for Electroceuticals Research
IEEE Spectrum, October 13, 2016
After Theranos
Nature Biotechnology, January 10, 2017
The implosion of blood diagnostics developer Theranos has raised the question: What is feasibly detectible in a drop of blood? 
Computer Diagnoses Skin Cancers
IEEE Spectrum, January 25, 2017
Clockwork Heart
IEEE Spectrum, January 11, 2017
Swiss researchers harness the heart's energy using one of their most famous inventions: the watch 
One-Step Optogenetics for Hacking the Nervous System
IEEE Spectrum, February 20, 2017
Sparking Memories With Electrical Stimulation
IEEE Spectrum, April 20, 2017
Amoeba-Like Robot Programmed With DNA
IEEE Spectrum, March 7, 2017
Digital Farming Attracts Cash to Agtech Startups
Nature Biotechnology, May 9, 2017